专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

DD160278A1 未知
公开(公告)号：DD160278A1
公开(公告)日：1983-05-25
申请号：DD21755979
申请日：1979-12-12
申请人： KIRSTEIN DIETER , MOHR PETER , FILIPIAK MARIAN , KRAUZE JERZY , SCHUBERT FLORIAN
发明人： KIRSTEIN DIETER , MOHR PETER , FILIPIAK MARIAN , KRAUZE JERZY , SCHUBERT FLORIAN
IPC分类号： C08F8/30 , C12N20060101 , C12N11/08

2. 发明专利

DD152808A1 未知
公开(公告)号：DD152808A1
公开(公告)日：1981-12-09
申请号：DD22152580
申请日：1980-06-02
申请人： FILIPIAK MARIAN , KRAUZE JERZY , KIRSTEIN DIETER , MOHR PETER
发明人： FILIPIAK MARIAN , KRAUZE JERZY , KIRSTEIN DIETER , MOHR PETER
IPC分类号： C07C20060101 , C12N11/04

3. 发明专利

DD157107A1 未知
公开(公告)号：DD157107A1
公开(公告)日：1982-10-13
申请号：DD22714181
申请日：1981-01-22
申请人： KUEHN MANFRED , KIRSTEIN DIETER , SCHELLER FRIEDER , SCHUBERT FLORIAN , MOHR PETER
发明人： KUEHN MANFRED , KIRSTEIN DIETER , SCHELLER FRIEDER , SCHUBERT FLORIAN , MOHR PETER
IPC分类号： C12P19/36 , C12N11/08

4. 发明专利

DD145428A1 未知
公开(公告)号：DD145428A1
公开(公告)日：1980-12-10
申请号：DD21246679
申请日：1979-04-25
申请人： KIRSTEIN DIETER , KAHRIG ERWIN , MOHR PETER , BESSERDICH HARTMUT , EPPERLEIN JOACHIM , KALLIES KARL HEINZ
发明人： KIRSTEIN DIETER , KAHRIG ERWIN , MOHR PETER
IPC分类号： G01N33/16

5. 发明申请

WO2012083185A3 PEPTIDE-BASED IN VIVO SIRNA DELIVERY SYSTEM 审中-公开
标题翻译：基于肽基于血液SIRNA递送系统
公开(公告)号：WO2012083185A3
公开(公告)日：2013-10-10
申请号：PCT/US2011065525
申请日：2011-12-16
申请人： ARROWHEAD RES CORP , ROZEMA DAVID B , LEWIS DAVID L , WAKEFIELD DARREN H , KITAS ERIC , HADWIGER PHILIPP , WOLFF JON A , ROEHL INGO , MOHR PETER , HOFFMAN TORSTEN , JAHN-HOFMANN KERSTIN , MUELLER HANS MARTIN , OTT GUENTHER , BLOKHIN ANDREI V , BENSON JONATHAN D , CARLSON JEFFREY C
发明人： ROZEMA DAVID B , LEWIS DAVID L , WAKEFIELD DARREN H , KITAS ERIC , HADWIGER PHILIPP , WOLFF JON A , ROEHL INGO , MOHR PETER , HOFFMAN TORSTEN , JAHN-HOFMANN KERSTIN , MUELLER HANS MARTIN , OTT GUENTHER , BLOKHIN ANDREI V , BENSON JONATHAN D , CARLSON JEFFREY C
IPC分类号： A61K31/713
CPC分类号： A61K47/48261 , A61K47/549 , A61K47/64 , A61K47/6415 , C12N15/111 , C12N2310/14 , C12N2310/351 , C12N2310/3515 , C12N2320/32
摘要： The present invention is directed compositions for targeted delivery of RNA interference (RNAi) polynucleotides to hepaiocytes in vivo. Targeted RNAi polynucleotides are administered together with co-targeted me!ittm dehvery peptides. Dehvery peptides provide membrane penetration faction for movement of the RNAi polynucleotides from outside the cell to inside the cell. Reversible modification provides physiological responsiveness to the delivery peptides.
摘要翻译：本发明是用于在体内靶向将RNA干扰（RNAi）多核苷酸递送至肝细胞的组合物。靶向的RNAi多核苷酸与共同靶向的我和其他多肽一起施用。去卵肽提供膜穿透力，用于从细胞外部到细胞内的RNAi多核苷酸的移动。可逆修饰提供对递送肽的生理反应性。

6. 发明申请

WO2009068468A3 PYRIDINE COMPOUNDS 审中-公开
标题翻译：吡啶化合物
公开(公告)号：WO2009068468A3
公开(公告)日：2010-04-22
申请号：PCT/EP2008065911
申请日：2008-11-20
申请人： HOFFMANN LA ROCHE , HAAP WOLFGANG , HEBEISEN PAUL , KITAS ERIC A , KUHN BERND , MOHR PETER , WESSEL HANS PETER
发明人： HAAP WOLFGANG , HEBEISEN PAUL , KITAS ERIC A , KUHN BERND , MOHR PETER , WESSEL HANS PETER
IPC分类号： C07D213/75 , A61K31/64 , A61P3/00 , C07D401/12 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/14
CPC分类号： C07D213/75 , C07D401/12 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/14
摘要： Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof wherein the residues have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions.
摘要翻译：式（I）化合物及其药学上可接受的盐和酯，其中残基具有权利要求1中给出的含义，其可以以药物组合物的形式使用。

7. 发明申请

WO2008148710A3 ARYLOXAZOLE, ARYLOXADIAZOLE AND BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF SOMATOSTATINS RECEPTOR ACTIVITY 审中-公开
标题翻译：作为SOMATOSTATINS受体活性的调节剂的阿唑氧唑，阿魏酸和苯并咪唑衍生物
公开(公告)号：WO2008148710A3
公开(公告)日：2009-04-09
申请号：PCT/EP2008056674
申请日：2008-05-30
申请人： HOFFMANN LA ROCHE , CHRIST ANDREAS D , MARTIN RAINER E , MOHR PETER
发明人： CHRIST ANDREAS D , MARTIN RAINER E , MOHR PETER
IPC分类号： C07D401/12 , A61K31/4468 , A61P3/10 , C07D413/12
CPC分类号： C07D413/12 , C07D401/12
摘要： This invention relates to compounds of the formula (I) wherein X is O or NR8, Y is CR7 or N, and R1 to R8 are as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
摘要翻译：本发明涉及式（I）的化合物，其中X为O或NR8，Y为CR7或N，R1至R8如说明书中所定义，及其药学上可接受的盐。本发明还涉及含有这些化合物的药物组合物，其制备方法及其用于治疗和/或预防与调节SST受体亚型5相关的疾病的用途。

8. 发明申请

WO2006074637A3 MULTI-CHAMBER HEAT ACCUMULATOR WHICH IS USED TO STORE THERMAL ENERGY AND TO PRODUCE ELECTRIC ENERGY 审中-公开
标题翻译：多功能插槽热存储器，用于存储热能用于产生电能
公开(公告)号：WO2006074637A3
公开(公告)日：2006-08-31
申请号：PCT/DE2006000018
申请日：2006-01-09
申请人： GEOTEX INGENIEURGESELLSCHAFT F , MOHR PETER
发明人： MOHR PETER
IPC分类号： F28D20/00
CPC分类号： F28D20/0056 , Y02E60/142
摘要： The invention relates to a multi-chamber heat accumulator which is used to store thermal energy and to produce electric energy. Said multi-chamber heat accumulator has a trench-like structure which is introduced into the base, having a lower part, a, in particular, surrounding lateral wall and a cover. The trench-like structure has at least one inner area which is provided with a solid trench-like filling and at least one outer area with a second solid trench-like filling. The outer area at least partially surrounds the inner area. The trench-like filling of the inner area is separated, at least sectionally, from the trench-like filling of the outer area, by means of at least one separating wall. The inner area comprises at least one first pipe system which is provided with at least one inlet which is arranged in the inner area and at least one outlet emerging from the inner area which is used to guide the liquids through, which is arranged, at least sectionally, in the material of the first trench-like filling of the inner area. The invention also relates to a method for producing electric energy, comprising the following steps a) a multi-chamber heat accumulator is provided according to the inventive claims, b) energy is fed to the inner area via the first pipe system by guiding heated fluid such that the temperature of the inner area is on average at least 110° C, c) the thermal energy is fed and stored in the inner area in order to evaporate a work fluid, in particular, a mixture comprising ammonia and water, or to evaporate liquid, slightly volatile organic compounds or to evaporate liquefied inert gases, d) at least one steam turbine is driven by the steam emerging from the work fluid during the evaporation process and e) the kinetic energy is converted into electric energy by the moving steam turbine.
摘要翻译：本发明涉及一种多室型蓄热用于储存热能以及用于包括鞋底，一个特别周，侧壁和盖的生成包括一个电能源，在地面上，凹坑结构在特定凹陷，其中，所述坑结构的至少一个内区与第一固体坑填充和填充物包括与第二固体坑的至少一个外部区，和外区，内区至少部分地围绕所述内部区域的凹坑填充从外区的凹坑填充至少局部由至少一个分隔壁隔开，并且其中所述内区包括至少一个第一管道系统具有至少一个进气口进入内部区域并从流体通过内部区域的至少一个出口，所述vorlie至少部分地在所述内区的第一坑填充的材料 GT。此外，本发明涉及一种方法，用于经由所述第一管道系统与被加热的流体的流路的装置，根据前述权利要求中任一项产生电能，其包括以下步骤：a）提供多室储热单元，b）将能量转换成内区，以使温度上平均的内区为至少110℃，c。使用供给到内部区域和所存储的热能用于汽化的工作流体，特别是包括氨和水的混合物），或以蒸发液体，高挥发性有机化合物或用于汽化液化惰性气体，D）通过驱动过程中从所述膨胀工作流体蒸汽和e蒸发过程中产生的至少一个蒸汽轮机）的移动蒸汽涡轮的动能转换成电能。

9. 发明申请

WO2012083185A2 PEPTIDE-BASED IN VIVO SIRNA DELIVERY SYSTEM 审中-公开
标题翻译：基于肽基于血液SIRNA递送系统
公开(公告)号：WO2012083185A2
公开(公告)日：2012-06-21
申请号：PCT/US2011065525
申请日：2011-12-16
申请人： ARROWHEAD RES CORPORATIONS , ROZEMA DAVID B , LEWIS DAVID L , WAKEFIELD DARREN H , KITAS ERIC , HADWIGER PHILIPP , WOLFF JON A , ROEHL INGO , MOHR PETER , HOFFMAN TORSTEN , JAHN-HOFMANN KERSTIN , MUELLER HANS MARTIN , OTT GUENTHER , BLOKHIN ANDREI V , BENSON JONATHAN D , CARLSON JEFFREY C
发明人： ROZEMA DAVID B , LEWIS DAVID L , WAKEFIELD DARREN H , KITAS ERIC , HADWIGER PHILIPP , WOLFF JON A , ROEHL INGO , MOHR PETER , HOFFMAN TORSTEN , JAHN-HOFMANN KERSTIN , MUELLER HANS MARTIN , OTT GUENTHER , BLOKHIN ANDREI V , BENSON JONATHAN D , CARLSON JEFFREY C
CPC分类号： A61K47/48261 , A61K47/549 , A61K47/64 , A61K47/6415 , C12N15/111 , C12N2310/14 , C12N2310/351 , C12N2310/3515 , C12N2320/32
摘要： The present invention is directed compositions for targeted delivery of RNA interference (RNAi) polynucleotides to hepaiocytes in vivo. Targeted RNAi polynucleotides are administered together with co-targeted me!ittm dehvery peptides. Dehvery peptides provide membrane penetration faction for movement of the RNAi polynucleotides from outside the cell to inside the cell. Reversible modification provides physiological responsiveness to the delivery peptides.
摘要翻译：本发明是用于在体内靶向将RNA干扰（RNAi）多核苷酸递送至肝细胞的组合物。靶向的RNAi多核苷酸与共同靶向的我和其他多肽一起施用。去卵肽提供膜穿透力，用于从细胞外部到细胞内的RNAi多核苷酸的移动。可逆修饰提供对递送肽的生理反应性。

10. 发明申请

WO02084890A2 INTEGRATED TELECOMMUNICATIONS CABINET SYSTEM WITH DSX ASSEMBLIES AND MULTIPLEXERS 审中-公开
标题翻译：集成电信系统与DSX装配和多路复用器
公开(公告)号：WO02084890A2
公开(公告)日：2002-10-24
申请号：PCT/US0212381
申请日：2002-04-17
申请人： TELECT INC , VERCRUYSSEN JAMES , MOHR PETER , THORPE JON
发明人： VERCRUYSSEN JAMES , MOHR PETER , THORPE JON
IPC分类号： H01R24/58 , H04J3/02 , H04J3/16 , H04Q1/02 , H04Q1/06 , H04B
CPC分类号： H04J3/1623 , H04J3/02 , H04Q1/025 , H04Q1/06 , H04Q1/15 , H04Q2201/10 , H04Q2201/12
摘要： A telecommunications cabinet system in which a cabinet (120) with a first end (120a) and a second end (120b) includes a plurality of DSX-1 and/or DSX-3 jack assemblies (130 and 134) and at least one multiplexer (121), are mounted such that they may be accessed from an end of the cabinet framework (120). The preferred system includes fifty-six DSX-1 jack assemblies (130 and 134) and two active M13's (121 and 126), with two standby or redundant M13's being available for use.
摘要翻译：一种电信柜系统，其中具有第一端（120a）和第二端（120b）的机柜（120）包括多个DSX-1和/或DSX-3插座组件（130和134）和至少一个多路复用器（121）安装成使得它们可以从机壳框架（120）的端部进入。首选系统包括五十六个DSX-1插孔组件（130和134）和两个有源M13（121和126），两个备用或冗余M13可供使用。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式